Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | LIMK1 | P53667 | 2/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.31 |
| ▸ | TNKS | O95271 | 1/20 | 0.31 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.31 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23595279 | 1.00 | ALOX5 (0.33) | ALOX5MAPTRXFP1KDM4EATM | |
| SCHEMBL23595278 | 0.99 | MAPT (0.33) | ALOX5MAPTRXFP1KDM4EATM | |
| SCHEMBL18505620 | 0.99 | MAPT (0.33) | ALOX5MAPTRXFP1KDM4EATM | |
| SCHEMBL20032239 | 0.98 | ALOX5 (0.34) | ALOX5MAPTRXFP1KDM4EATM | |
| SCHEMBL23595018 | 0.98 | MAPT (0.34) | ALOX5MAPTRXFP1KDM4EATM | |
| SCHEMBL23595280 | 0.98 | MAPT (0.34) | ALOX5MAPTRXFP1KDM4EATM | |
| SCHEMBL25133216 | 0.98 | ALOX5 (0.34) | ALOX5MAPTRXFP1KDM4EATM | |
| SCHEMBL23595320 | 0.96 | LIMK1 (0.33) | ALOX5MAPTRXFP1KDM4EATM | |
| SCHEMBL25133755 | 0.96 | ALOX5 (0.33) | ALOX5MAPTLIMK1PIM3TNKS | |
| SCHEMBL25660824 | 0.96 | GAA (0.33) | ALOX5MAPTRXFP1LIMK1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230099759-A1 | POLYCYCLIC COMPOUND, MATERIAL FOR AN ORGANIC ELECTROLUMINESCENCE DEVICE AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE POLYCYCLIC COMPOUND | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-03-30 | — | — | US | disclosed |
| WO-2021132733-A1 | POLYCYCLIC COMPOUND, MATERIAL FOR AN ORGANIC ELECTROLUMINESCENCE DEVICE AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE POLYCYCLIC COMPOUND | IDEMITSU KOSAN CO., LTD. (JP) | 2021-07-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230099759-A1 | POLYCYCLIC COMPOUND, MATERIAL FOR AN ORGANIC ELECTROLUMINESCENCE DEVICE AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE POLYCYCLIC COMPOUND | SLCO4C1, SLCO1A2, PORCN | ALOX5 3941/4885MAPT 961/4885RXFP1 4870/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.